During the third year of the Hospital Readmission Reduction Program, CMS will penalize more hospitals than it did during the second and third years of the program; however, the overall readmission rate for Medicare beneficiaries is down.
During the third year of the Hospital Readmission Reduction Program, CMS will penalize more hospitals than it did during the first and second years of the program.
An analysis of CMS data by Kaiser Health News found that 2610 hospitals will be penalized during fiscal year 2015, up 17.3% from 2225, in FY 2014. Fines for these hospitals with high readmission rates will be up significantly and total an estimated $428 million, which is up 88.5% from $227 million.
A total of 39 hospitals will receive the largest penalty allowed, according to Kaiser.
However, the nation’s readmission rate is dropping. Last year, 18% of hospitalized Medicare patients were readmitted within 30 days, which cost Medicare $26 billion. Approximately $17 billion of that total is potentially avoidable, according to CMS data.
At the end of last year, CMS had reported that readmissions for Medicare beneficiaries had fallen for the second year in a row.
As a result of the fines being levied, the penalized hospitals will receive lower payments for every Medicare patient stay from October 1, 2014, through September 30, 2015. Some fines are as small as a hundredth of a percent, but others are losing 3% of each payment, according to Kaiser.
The analysis explained that part of the reason for higher and more widespread fines is that Medicare began evaluating readmissions for 2 new categories of patients. Since the beginning of the penalties in 2012, Medicare has assessed readmission rates for heart failure, heart attack, and pneumonia patients. Now, Medicare is examining those initially admitted for elective knee or hip replacements and those suffering lung conditions, in addition to the original 3 categories.
Read the full report on Kaiser: http://www.kaiserhealthnews.org/Stories/2014/October/02/Medicare-readmissions-penalties-2015.aspx
Care Quality Metrics in Medicare During COVID-19 Pandemic
August 12th 2025Medicare Advantage outperformed traditional Medicare on clinical quality measures before and during the COVID-19 pandemic; mid-pandemic, however, traditional Medicare narrowed the gap on some in-person screenings.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More